The FDA has proposed to withdraw its approval of avacopan for ANCA-associated vasculitis, alleging that employees of the ...
Morning Overview on MSN
FDA says "manipulated" data backed approval, moves to withdraw the drug
The FDA has moved to pull Tavneos (avacopan) from the U.S. market, alleging that manipulated clinical trial data propped up the drug’s 2021 approval for a rare and potentially fatal blood vessel ...
On May 13, the Food and Drug Administration (FDA) approved decitabine and cedazuridine (Inqovi) tablets in combination with venetoclax (Venclexta) for adults newly diagnosed with AML who are aged 75 ...
(Corrects to clarify the total number of patients in the study in paragraph 10) May 27 (Reuters) - The U.S. Food and Drug ...
An official from the US Food and Drug Administration (FDA) on Monday presented three case studies demonstrating how sponsors effectively utilized real-world evidence (RWE) and real-world data (RWD) to ...
Morning Overview on MSN
The FDA just cleared a new kind of br...
For roughly four in every ten women whose estrogen receptor-positive breast cancer has spread and stopped responding to ...
Foundation Medicine previously received companion diagnostic approval for its FoundationOne Liquid CDx assay alongside EMD Serono's Tepmetko.
Health system pharmacists and clinicians are monitoring a wave of drug approvals expected throughout 2026, including first-in-class therapies and expanded uses of existing drugs with implications for ...
The U.S. Food and Drug Administration's decision to withhold approval of a new skin cancer treatment fell like a hammer on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results